Wednesday, August 15, 2018
 
 
Company News: Page (1) of 1 - 07/18/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
Survey to Explore Issues Affecting Care Providers, Patients and Programs
(July 18, 2018)

ROCKVILLE, Md., July 18, 2018 /PRNewswire/ -- Building on the success of last year's collaboration, the Association of Community Cancer Centers (ACCC) and Advisory Board's Oncology Roundtable are again conducting a comprehensive survey that will explore how cancer programs across the country are moving forward and adapting in the midst of exciting, increasingly rapid advances in cancer care coupled with unprecedented change underway across the U.S. healthcare system.  Funding and support for the "Trending Now in Cancer Care" survey is provided by Pfizer Oncology.

"With a record number of respondents to last year's survey, ACCC is pleased to partner again with the Advisory Board's Oncology Roundtable to create this valuable snapshot focusing on how cancer programs are faring in today's healthcare environment," said Christian G. Downs, JD, MHA, ACCC Executive Director. "Our collaboration in conducting this trends survey brings the oncology community much-needed perspective on strengths and challenges of cancer programs in a health system that continues to struggle with transformation."

The 2018 "Trending Now in Cancer Care" survey will address:



  • Staffing retention and turnover
  • Burnout and building resilience
  • Leveraging technology, including telehealth utilization, EHR interoperability
  • Treatment advances, including biomarker testing protocols
  • Familiarity with new immunotherapies, including CAR T-cell therapy
  • Multidisciplinary approaches to care
  • Challenges to clinical trial participation

Findings will help cancer programs assess their strengths and areas for improvement, and plan strategically for the future. Survey participants will receive a customized report, comparing their program-type cohort data to national results.

"This year's survey will help cancer programs identify strategies to ensure success in a changing healthcare environment," said Deirdre Saulet, PhD, Practice Manager for Oncology Roundtable at Advisory Board. "We are grateful for the opportunity to continue our partnership with ACCC on this survey."

The "Trending Now in Cancer Care" survey is open to all oncology programs in the United States. Respondents do not need to be members of ACCC or Advisory Board to participate. Any members of the multidisciplinary cancer team, including cancer program executives and administrators, clinical staff, and physicians are invited to take the survey.

Launched on July 9, 2018, the survey will be available online for approximately four weeks.

Media contact: Association of Community Cancer Centers, Lori Gardner, Senior Director
Communications & Marketing, 301.984.9496 ext. 226

Cision View original content:http://www.prnewswire.com/news-releases/association-of-community-cancer-centers-and-advisory-board-launch-9th-annual-trends-in-cancer-care-survey-300682793.html

SOURCE Association of Community Cancer Centers

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA,Science,Medical,Cancer,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
  • Global Spinal Fusion Devices Market Expected to Reach USD 6.8 Billion By 2024: Zion Market Research

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Pricing of Public Offering of Common Stock
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
  • CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
  • Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines